ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

AACR Statement on Precancers Plays Key Role in NCI Agenda

May 30, 2003

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997

In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item

May 16, 1980